NasdaqCM - Nasdaq Real Time Price USD

Viking Therapeutics, Inc. (VKTX)

Compare
60.81 -1.22 (-1.97%)
As of 2:27 PM EDT. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
368,490.00
168,529.00
210,662.00
256,502.00
--
Total Liabilities Net Minority Interest
20,071.00
23,207.00
8,778.00
12,158.00
--
Total Equity Gross Minority Interest
348,419.00
145,322.00
201,884.00
244,344.00
--
Total Capitalization
348,419.00
145,322.00
201,884.00
244,344.00
--
Common Stock Equity
348,419.00
145,322.00
201,884.00
244,344.00
--
Capital Lease Obligations
1,260.00
1,564.00
29.00
359.00
--
Net Tangible Assets
348,419.00
145,322.00
201,884.00
244,344.00
--
Working Capital
348,090.00
145,093.00
201,750.00
243,975.00
--
Invested Capital
348,419.00
145,322.00
201,884.00
244,344.00
--
Tangible Book Value
348,419.00
145,322.00
201,884.00
244,344.00
--
Total Debt
1,260.00
1,564.00
29.00
359.00
--
Share Issued
102,307.02
80,450.51
78,248.40
73,215.94
--
Ordinary Shares Number
100,113.77
78,257.26
78,248.40
73,215.94
--
Treasury Shares Number
2,193.25
2,193.25
--
--
--
12/31/2019 - 4/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers